Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.
J.F. Geschwind(Johns Hopkins University), Peter L. Pedersen(Johns Hopkins University), Michael Torbenson(Mayo Clinic), Young Hee Ko(Johns Hopkins University), Carolyn Magee(Johns Hopkins University)
PubMed
July 15, 2002
Cited by 257
Related Papers
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Ion motive ATPases. I. Ubiquity, properties, and significance to cell function
|Trends in Biochemical Sciences|1987|966
Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria
|Oncogene|2006|756
Tumor Mitochondria and the Bioenergetics of Cancer Cells
|Progress in tumor research|2015|715
The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane.
|Journal of Biological Chemistry|1986|691